| Ligand | Template | Human Adenosine Receptor models |
|---|---|---|
 ADENOSINE | 2YDO | A1 A2A A2B A3 |
 N-ETHYL-5'-CARBOXAMIDO ADENOSINE | 2YDV | A1 A2A A2B A3 |
 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo [1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | 3EML | A1 A2A A2B A3 |
 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo [1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | 3PWH | A1 A2A A2B A3 |
 6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5- (ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide | 3QAK | A1 A2A A2B A3 |
 N-(2-aminoethyl)-2-[4-(2,6-dioxo-1,3-dipropyl- 2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetamide | 3REY | A1 A2A A2B A3 |
 CAFFEINE | 3RFM | A1 A2A A2B A3 |
 6-(2,6-dimethylpyridin-4-yl)-5-phenyl-1,2,4- triazin-3-amine | 3UZA | A1 A2A A2B A3 |
 4-(3-amino-5-phenyl-1,2,4-triazin-6-yl)- 2-chlorophenol | 3UZC | A1 A2A A2B A3 |
 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo [1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | 3VG9 | A1 A2A A2B A3 |
 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo [1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | 3VGA | A1 A2A A2B A3 |
 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo [1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | 4EIY | A1 A2A A2B A3 |